Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Dave Weldon is a critic of the FDA, CDC and vaccines. Many wonder if he’s the best choice to lead the CDC amid measles, flu ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

Advancements in AI-driven flood forecasting are enabling faster, more efficient detection and response. For example, Google ...

An Ohio woman who served prison time for allegedly failing to disclose her HIV status to her ex-fiancé is sharing her story as part of an effort calling for the ...

After Trump’s order prompted a public outcry over the halting of such humanitarian programs, Rubio issued two waivers ...